- Home
- JVA vs RDHL Comparison
JVA vs RDHL Comparison
Compare JVA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- RDHL
- Stock Information
- Founded
- JVA 1971
- RDHL 2009
- Country
- JVA United States
- RDHL Israel
- Employees
- JVA N/A
- RDHL N/A
- Industry
- JVA Packaged Foods
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- RDHL Health Care
- Exchange
- JVA Nasdaq
- RDHL Nasdaq
- Market Cap
- JVA N/A
- RDHL 8.6M
- IPO Year
- JVA 2005
- RDHL N/A
- Fundamental
- Price
- JVA $3.68
- RDHL $6.50
- Analyst Decision
- JVA
- RDHL
- Analyst Count
- JVA 0
- RDHL 0
- Target Price
- JVA N/A
- RDHL N/A
- AVG Volume (30 Days)
- JVA 163.7K
- RDHL 21.6K
- Earning Date
- JVA 02-07-2025
- RDHL 01-03-2025
- Dividend Yield
- JVA N/A
- RDHL N/A
- EPS Growth
- JVA N/A
- RDHL N/A
- EPS
- JVA 0.20
- RDHL N/A
- Revenue
- JVA $76,111,698.00
- RDHL $3,707,000.00
- Revenue This Year
- JVA N/A
- RDHL $224.90
- Revenue Next Year
- JVA N/A
- RDHL $82.69
- P/E Ratio
- JVA $18.69
- RDHL N/A
- Revenue Growth
- JVA 17.27
- RDHL N/A
- 52 Week Low
- JVA $0.81
- RDHL $6.00
- 52 Week High
- JVA $4.66
- RDHL $40.50
- Technical
- Relative Strength Index (RSI)
- JVA 47.99
- RDHL 38.21
- Support Level
- JVA $3.92
- RDHL $6.00
- Resistance Level
- JVA $4.66
- RDHL $7.30
- Average True Range (ATR)
- JVA 0.40
- RDHL 0.51
- MACD
- JVA -0.07
- RDHL -0.09
- Stochastic Oscillator
- JVA 22.22
- RDHL 21.10
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.